Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 305

1.

Identification of urinary metabolites that distinguish membranous lupus nephritis from proliferative lupus nephritis and focal segmental glomerulosclerosis.

Romick-Rosendale LE, Brunner HI, Bennett MR, Mina R, Nelson S, Petri M, Kiani A, Devarajan P, Kennedy MA.

Arthritis Res Ther. 2011;13(6):R199. doi: 10.1186/ar3530. Epub 2011 Dec 7.

2.

Nonlupus nephritides in patients with systemic lupus erythematosus: a comprehensive clinicopathologic study and review of the literature.

Baranowska-Daca E, Choi YJ, Barrios R, Nassar G, Suki WN, Truong LD.

Hum Pathol. 2001 Oct;32(10):1125-35.

PMID:
11679948
3.

Urinary high-mobility group box-1 associates specifically with lupus nephritis class V.

Jog NR, Blanco I, Lee I, Putterman C, Caricchio R.

Lupus. 2016 Dec;25(14):1551-1557. Epub 2016 Apr 12.

4.

Outcome of reclassification of World Health Organization (WHO) class III under International Society of Nephrology-Renal Pathology Society (ISN-RPS) classification: retrospective observational study.

Hwang J, Kim HJ, Oh JM, Ahn JK, Lee YS, Lee J, Kim YG, Huh WS, Seo J, Koh EM, Cha HS.

Rheumatol Int. 2012 Jul;32(7):1877-84. doi: 10.1007/s00296-011-1887-x. Epub 2011 Mar 27.

PMID:
21442173
5.

Urinary free light chain is a potential biomarker for ISN/RPS class III/IV lupus nephritis.

Hanaoka M, Gono T, Kawaguchi Y, Uchida K, Koseki Y, Katsumata Y, Kaneko H, Takagi K, Ichida H, Nitta K, Yamanaka H.

Rheumatology (Oxford). 2013 Dec;52(12):2149-57. doi: 10.1093/rheumatology/ket108. Epub 2013 Mar 5.

PMID:
23463805
6.

Renal outcomes in mixed proliferative and membranous lupus nephritis (Class III/IV + V): A long-term observational study.

Ikeuchi H, Hiromura K, Kayakabe K, Tshilela KA, Uchiyama K, Hamatani H, Sakairi T, Kaneko Y, Maeshima A, Nojima Y.

Mod Rheumatol. 2016 Nov;26(6):908-913. doi: 10.3109/14397595.2016.1158896. Epub 2016 Apr 26.

PMID:
27115200
7.

Frequency of class III and IV nephritis in systemic lupus erythematosus without clinical renal involvement: an analysis of predictive measures.

Wakasugi D, Gono T, Kawaguchi Y, Hara M, Koseki Y, Katsumata Y, Hanaoka M, Yamanaka H.

J Rheumatol. 2012 Jan;39(1):79-85. doi: 10.3899/jrheum.110532. Epub 2011 Nov 15.

PMID:
22089455
8.

The value of repeat biopsy in the management of lupus nephritis: an international multicentre study in a large cohort of patients.

Pagni F, Galimberti S, Goffredo P, Basciu M, Malachina S, Pilla D, Galbiati E, Ferrario F.

Nephrol Dial Transplant. 2013 Dec;28(12):3014-23. doi: 10.1093/ndt/gft272. Epub 2013 Aug 24.

PMID:
23975838
9.

Podocyte injury in pure membranous and proliferative lupus nephritis: distinct underlying mechanisms of proteinuria?

Rezende GM, Viana VS, Malheiros DM, Borba EF, Silva NA, Silva C, Leon EP, Noronha IL, Bonfa E.

Lupus. 2014 Mar;23(3):255-62. doi: 10.1177/0961203313517152. Epub 2013 Dec 19.

PMID:
24356611
10.
11.

The ISN/RPS 2003 classification of lupus nephritis: an assessment at 3 years.

Markowitz GS, D'Agati VD.

Kidney Int. 2007 Mar;71(6):491-5. Epub 2007 Jan 31. Review.

12.

Revised classification of lupus nephritis is valuable in predicting renal outcome with an indication of the proportion of glomeruli affected by chronic lesions.

Hiramatsu N, Kuroiwa T, Ikeuchi H, Maeshima A, Kaneko Y, Hiromura K, Ueki K, Nojima Y.

Rheumatology (Oxford). 2008 May;47(5):702-7. doi: 10.1093/rheumatology/ken019. Epub 2008 Apr 4.

PMID:
18390590
13.

Renal histological findings in adults in Jamaica.

Soyibo AK, Shah D, Barton EN, Williams W, Smith R.

West Indian Med J. 2009 Jun;58(3):265-9.

PMID:
20043536
14.

Renal biopsy findings in new-onset systemic lupus erythematosus with clinical renal disease.

Wen YK.

Int Urol Nephrol. 2011 Sep;43(3):801-6. doi: 10.1007/s11255-011-9911-3. Epub 2011 Feb 20.

PMID:
21336956
15.

The difference between lupus nephritis class IV-G and IV-S in Koreans: focus on the response to cyclophosphamide induction treatment.

Kim YG, Kim HW, Cho YM, Oh JS, Nah SS, Lee CK, Yoo B.

Rheumatology (Oxford). 2008 Mar;47(3):311-4. doi: 10.1093/rheumatology/kem365. Epub 2008 Jan 19.

PMID:
18204087
16.

Classification of lupus nephritis.

Markowitz GS, D'Agati VD.

Curr Opin Nephrol Hypertens. 2009 May;18(3):220-5. Review.

PMID:
19374008
17.
18.

Large variability of the activity and chronicity indexes within and between histological classes of lupus nephritis.

Azoicăi T, Belibou IM, Lozneanu L, Giuşcă SE, Cojocaru E, Căruntu ID.

Rom J Morphol Embryol. 2017;58(1):73-78.

19.

Urinary dedifferentiated podocytes as a non-invasive biomarker of lupus nephritis.

Perez-Hernandez J, Olivares MD, Forner MJ, Chaves FJ, Cortes R, Redon J.

Nephrol Dial Transplant. 2016 May;31(5):780-9. doi: 10.1093/ndt/gfw002. Epub 2016 Feb 29.

PMID:
26932688
20.

Significance of global versus segmental subclassification of class III and IV lupus nephritis: a single center experience.

Nasri H, Baradaran A, Rafieian-kopaei M, Mubarak M.

Acta Reumatol Port. 2015 Apr-Jun;40(2):138-44.

Supplemental Content

Support Center